Home/Filings/4/0001179110-12-006525
4//SEC Filing

GAY ROBERT C 4

Accession 0001179110-12-006525

CIK 0001274792other

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 4:13 PM ET

Size

18.3 KB

Accession

0001179110-12-006525

Insider Transaction Report

Form 4
Period: 2012-04-03
GAY ROBERT C
Director
Transactions
  • Conversion

    Common Stock

    2012-04-03+175,316175,316 total
  • Conversion

    Series D Convertible Preferred Stock

    2012-04-03142,8570 total(indirect: See footnote)
    Common Stock (142,857 underlying)
  • Conversion

    Common Stock

    2012-04-03+142,857318,173 total
  • Conversion

    Common Stock

    2012-04-03+175,316493,489 total(indirect: See footnote)
  • Conversion

    Common Stock

    2012-04-03+142,857636,346 total(indirect: See footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2012-04-03113,5860 total
    Common Stock (175,316 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2012-04-03142,8570 total
    Common Stock (142,857 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2012-04-03113,5860 total(indirect: See footnote)
    Common Stock (175,316 underlying)
Footnotes (3)
  • [F1]Each share of Series B Convertible Preferred Stock automatically converted into approximately 1.5435 shares of Common Stock upon the closing of the issuer's initial public offering and had no expiration date.
  • [F2]Each share of Series D Convertible Preferred Stock automatically converted into one share of Common Stock upon the closing of the issuer's initial public offering and had no expiration date.
  • [F3]These shares are held by the Robert C. Gay 1998 Family Trust, of which Dr. Gay is the grantor. Dr. Gay disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Issuer

MERRIMACK PHARMACEUTICALS INC

CIK 0001274792

Entity typeother

Related Parties

1
  • filerCIK 0001032566

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:13 PM ET
Size
18.3 KB